Dr. Haussam EI., UK, May 2011
"My bone disease before taking Osteoking was bilateral stage 1 AVN; only symptomatic on the right side with constant severe right groin pain.
I started Osteoking in June 2010. However, the decompression took off the pain completely on 30 June 2010. Osteoking has a siginificant added benefit after the operation that enhanced my recovery; allowed me to start my gym exercises 2 weeks after operation very gradually till after 3 months I was off the crutches and running 8 km in 15 minutes on a cycle and at high level of resistance.
My Orthopaedic Consultant was amazed about the speedy recovery which he was not expected until fater a year from the time of operation. In deed, the operation + Osteoking + regular exercises were the key towards regaining my bones healthy again.
I managed to lose weight so far 30 kg. Upon looking at my last MRI, disease process has stopped since Jan 2011 and bone filled up with healthy tissue as well as no secondary osteoarthritis.
I would like to thank all Osteoking team for the constant support and assurance" See more testmonials
|
|
 |
|
Product Researches |
In order to explore its mechanism
of the effects, extensive studies and researches have been conducted in foremost
level of biochemistry, histomorphology, molecular
biology for OsteoKing. The results show
that OsteoKing can reduce blood viscosity, improve
hemodynamics, reduce internal pressure of bone,
improve blood supply, reduce blood fat concentration,
reduce the formation of fat embolism and promote
the genetic expression of endogenous VEGF(Vascular
endothelial growth factor), cbf a1(core binding
factor a-1) and BMP-2(Bone morphogenetic proteins-2). It can also strengthen the activity of bone cells and inhibit osteoclast cells.
Observation with optical microscope, transmission
electron microscope and scanning electron microscope, the results showed
|
| The
general observation: |
|
|
|
|
|
No-treatment
control group: normal femoral head |
Model group:
modeling cartilage has become thin; the
bone trabecula has disordered and appeared
oily condition. |
OsteoKing
group: the thickness of cartilage is normal
and fat is little. |
| The
results observed with optical microscope: |
|
|
|
|
|
No-treatment
control group: normal femoral head |
Model group:
the bone trabecula has disordered and
become thinner, sparse. The medullar cavity
is full of empty lipid cells. |
OsteoKing
group: more new bone is formed on the
surface of bone trabecula. |
| The
results observed with transmission electron
microscope: |
|
|
|
|
|
Model group:
necrosis occurred, the medullar cavity
bled, collagen was disturbance |
Model group:
necrosis occurred, the medullar cavity
bled seriously, |
Model group:
bone tissues have become degenerately
necrosis and bleeding |
|
|
|
|
|
OsteoKing
group: new bone trabecula and original
bone trabecula |
OsteoKing
group: more blood capillary appeared |
OsteoKing
group: more osteoblasts and new bone cells
appeared |
| The
results observed with scanning electron
microscope: |
|
|
|
|
|
No-treatment
control group: the normal membranous structure
on the surface of bone trabecula |
Model group:
the membranous structure was destroyed |
OsteoKing
group: the membranous structure was normal
and the formation of bone was active |
|
Necrotic bone cells are
less in the OsteoKing group, more osteoblasts
and osteoclasts, new bone cells and bone matrix
are appeared as well as calcium deposit occurs.
The results observed with scanning electron microscope
indicate that more osteoblasts appeared on the
surface of bone trabecula. OsteoKing group has
remarkable superiority compares with model group.
Promoting the formation of blood vessel by promoting
the genetic expression of endogenous VEGF, effectively
improve the activity of osteoblasts and speed
the formation of bone cells.
VEGF (Vascular endothelial growth factor) is very
closely related to bone repair and plays a very
important role in the formation and repair of
bone. (Lieberman JR, et al. Instr Course Lect,
2003; 52:337-55. ?Carano RA, et al. Drug Discov
Today. 2003, 8(21): 980-989.?Yancopoulos GD,et
al. Nature. 2000, 407(6801):242-248. Review.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the expression of endogenous VEGF in the necrotic
femoral head and increase the expression volume
significantly. Compared with Model group, the
difference has statistics significance (p<0.05).
Promoting the development, differentiation, regulation
of osteoblasts and bone calcification by boosting
the genetic of cbf a1.
cbf a1 (core binding factor ?1) gene is osteogenesis
specificity transcription activation factor, It
plays a very important role during the development
and differentiation of the osteoblast and the
bone formation.(Ducy P, et al. Cell, 1997, 89(5):747~754.?Komori
T, et al. Cell, 1997, 89(5):755-764.?He J, et
al. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod, 2004, 97(2):239-245.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the repair of necrotic bone through promoting
the expression of cbf ?1 in the necrotic femoral
head and increase the expression volume significantly.
Compared with the model group, the difference
has statistics significance (p<0.05).
Inducting ossification and stimulating the formation
of bone cells by boosting the genetic of BMP-2.
BMP-2 (Bone morphogenetic proteins-2) has very
powerful activity in inducting ossification (Wozney
JM, et al. Science, 1988, 242(4885): 1528-1534.?Croteau
S,et al. Orthopedics, 1999, 22(7):686-695.?Shore
EM, et al. Clin Orthop, 1995, (311):199-209.)
Tested through the methods of immunohistochemistry,
hybridization in situ, real-time fluorescent fixed
quantity and PCR and verified each other then
draw the same conclusion that OsteoKing can promote
the repair of necrotic bone through promoting
the expression of BMP-2 in the necrotic femoral
head and increase the expression volume significantly.
Compared with the model group, the difference
has statistics significance (p<0.05).
The researches of OsteoKing are performed with
the latest modern methods and receive the scientific
data, from many angles and aspects to analysis
the mechanism of the effects of OsteoKing
deeply to the genetic level. Those provide solid
scientific data for the end user application. It is the top choice for maintaining the human bone health.
OsteoKing
has also been tested and applied on more
than ten thousands of clinical cases in many hospitals
in China, including the Shanghai Sixth People’s
Hospital, Beijing Ji Shui Tang Hospital, Beijing
No. 301 Hospital of PLA, Affiliated Hospital of
Beijing Medical University, Affiliated Hospital
of Guangzhou Sun Yat Sen Medical University, Guangzhou
Southern Hospital, Affiliated Hospital of Shandong
Traditional Chinese Medical University, Hubei
Tong Ji Hospital, Hubei Friendship Hospital, Affiliated
Hospital of Zhejiang University, Sichuan Provincial
People’s Hospital, Yunnan Provincial People’s
Hospital, Affiliated Hospital of Kunming Medical
College, the General Hospital of Chengdu Military
District, Affiliated Hospital of Harbin Medical
University, Affiliated Hospital of the Third Military
Medical University. OsteoKing has also been used
by the users in the US and Europe
and has been highly recommended by the doctors
and the patients. It was called "magic herbal product" by the user from UK and "water of life" by the user from Turkey.
|
|
|
 |
|